Drug Screening Technical Platform Based on siRNA Technology

CHGB has established the high through-put screening technical platform for functional genes and their correlative drug molecules, based on siRNA technology. The project has now entered the stage of large-scale screening for effective siRNAs of tumor correlative functional genes. We expect to find effective drug targets within two years, and can further develop drugs based on these targets.